Cryopraxis Criobiologia Ltda.   Report issue

For profit Phase 1 Phase 2
Founded: Rio de Janeiro Brazil (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2005
NCT01966042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Drugs in Phase 1 Trials (1)

autologous mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 2)

Lipodystrophy (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2